期刊文献+

^(13)C-methacetin breath test reproducibility study reveals persistent CYP1A2 stimulation on repeat examinations 被引量:1

^(13)C-methacetin breath test reproducibility study reveals persistent CYP1A2 stimulation on repeat examinations
暂未订购
导出
摘要 AIM: To find the most reproducible quantitative parameter of a standard 13C-methacetin breath test (13C-MBT). METHODS: Twenty healthy volunteers (10 female, 10 male) underwent the 13C-MBT after intake of 75 mg 13C-methacetin p.o. on three occasions. Short-and medium-term reproducibility was assessed with paired examinations taken at an interval of 2 and 18 d (medians), respectively. RESULTS: The reproducibility of the 1-h cumulative 13C recovery (AUC0-60), characterized by a coefficient of variation of 10%, appeared to be considerably better than the reproducibility of the maximum momentary 13C recovery or the time of reaching it. Remarkably, as opposed to the short gap between consecutive examinations, the capacity of the liver to handle 13C-methacetin increased slightly but statistically significantly when a repeat dose was administered after two to three weeks.Regarding the AUC0-60, the magnitude of this fixed bias amounted to 7.5%. Neither the time gap between the repeat examinations nor the gender of the subjects affected the 13C-MBT reproducibility. CONCLUSION: 13C-MBT is most reproducibly quantified by the cumulative 13C recovery, but the exactitude thereof may be modestly affected by persistent stimulation of CYP1A2 on repeat examinations. AIM: To find the most reproducible quantitative parameter of a standard 13C-methacetin breath test (13C-MBT). METHODS: Twenty healthy volunteers (10 female, 10 male) underwent the 13C-MBT after intake of 75 mg 13C-methacetin p.o. on three occasions. Short-and medium-term reproducibility was assessed with paired examinations taken at an interval of 2 and 18 d (medians), respectively. RESULTS: The reproducibility of the 1-h cumulative 13C recovery (AUC0-60), characterized by a coefficient of variation of 10%, appeared to be considerably better than the reproducibility of the maximum momentary 13C recovery or the time of reaching it. Remarkably, as opposed to the short gap between consecutive examinations, the capacity of the liver to handle 13C-methacetin increased slightly but statistically significantly when a repeat dose was administered after two to three weeks.Regarding the AUC0-60, the magnitude of this fixed bias amounted to 7.5%. Neither the time gap between the repeat examinations nor the gender of the subjects affected the 13C-MBT reproducibility. CONCLUSION: 13C-MBT is most reproducibly quantified by the cumulative 13C recovery, but the exactitude thereof may be modestly affected by persistent stimulation of CYP1A2 on repeat examinations.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第45期4979-4986,共8页 世界胃肠病学杂志(英文版)
基金 Supported by The Medical University of Silesia, contracts No. NN-1-106-06, KNW-1-043/08 and KNW-1-154/09
关键词 13C-Methacetin Breath test Isotope application in medicine Liver REPRODUCIBILITY CYP1A2 重复性 检查 试验 呼气 主战坦克 考试评估 定量参数
  • 相关文献

参考文献4

二级参考文献99

  • 1Yantorno SE,Kremers WK,Ruf AE,Trentadue JJ,Podest¨? LG,Villamil FG.MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure.Liver Transpl 2007; 13:822-828
  • 2Gow PJ,Warrilow S,Lontos S,Lubel J,Wongseelashote S,MacQuillan GC,Jones RM,Bellomo R,Angus PW.Time to review the selection criteria for transplantation in paracetamol-induced fulminant hepatic failure? Liver Transpl 2007; 13:1762-1763
  • 3O'Grady JG.Prognostication in acute liver failure:a tool or an anchor? Liver Transpl 2007; 13:786-787
  • 4Luketic VA,Shiffman ML,Fisher RA,Sanyal AJ,Purdum PP 3rd,Posner MP.Hepatic lidocaine metabolism is useful in the selection of patients in need of liver transplantation.Transplant Proc 1993; 25:1072-1074
  • 5Shiffman ML,Luketic VA,Sanyal AJ,Duckworth PF,Purdum PP 3rd,Contos MJ,Mills AS,Edinboro LE,Poklis A.Hepatic lidocaine metabolism and liver histology in patients with chronic hepatitis and cirrhosis.Hepatology 1994; 19:933-940
  • 6Escorsell A,Mas A,de la Mata M.Acute liver failure in Spain:analysis of 267 cases.Liver Transpl 2007; 13:1389-1395 Receiveddate:09/24/2008 Modifieddate:12/04/2008 Published:02/28/2009
  • 7Elias E.Liver failure and liver disease.Hepatology 2006; 43:S239-S242
  • 8Davis CL,Gonwa TA,Wilkinson AH.Identification of patients best suited for combined liver-kidney transplantation:part II.Liver Transpl 2002; 8:193-211
  • 9Han MK,Hyzy R.Advances in critical care management of hepatic failure and insufficiency.Crit Care Med 2006; 34:S225-S231
  • 10Blei AT.Selection for acute liver failure:have we got it right? Liver Transpl 2005; 11:S30-S34

共引文献40

同被引文献9

  • 1D.Festi,S.Capodicasa,L.Sandri,L.Colaiocco-Ferrante,T.Staniscia,E.Vitacolonna,A.Vestito,R.Simoni,G.Mazzella,P.Portincasa,E.Roda,A.Colecchia.Measurement of hepatic functional mass by means of ^(13)C-methacetin and ^(13)C-phenylalanine breath tests in chronic liver disease: Comparison with Child-Pugh score and serum bile acid levels[J].World Journal of Gastroenterology,2005,11(1):142-148. 被引量:35
  • 2P. Faybik,H. Hetz.Plasma Disappearance Rate of Indocyanine Green in Liver Dysfunction[J].Transplantation Proceedings.2006(3)
  • 3Hamizah Razlan,Nurhayaty Muhamad Marzuki,Mei-Ling Sharon Tai,Azhar-Shah Shamsul,Tze-Zen Ong,Sanjiv Mahadeva,Edoardo G. Giannini.Diagnostic Value of the <sup>13</sup>C Methacetin Breath Test in Various Stages of Chronic Liver Disease[J].Gastroenterology Research and Practice.2011
  • 4Gadi Lalazar,Yaron Ilan.Assessment of liver function in acute or chronic liver disease by the methacetin breath test: a tool for decision making in clinical hepatology[J].Journal of Breath Research.2009(4)
  • 5G.Lalazar,O.Pappo,T.Hershcovici,T.Hadjaj,M.Shubi,H.Ohana,N.Hemed,Y.Ilan.A continuous <sup>13</sup>C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT[J].Journal of Viral Hepatitis.2008(10)
  • 6O.GOETZE,N.SELZNER,H.FRUEHAUF,M.FRIED,T.GERLACH,B.MULLHAUPT.<sup>13</sup>C‐methacetin breath test as a quantitative liver function test in patients with chronic hepatitis C infection: continuous automatic molecular correlation spectroscopy compared to isotopic ratio mass spectrometry[J].Alimentary Pharmacology & Therapeutics.2007(2)
  • 7Edoardo Giannini,Paola Romagnoli,Alberto Fasoli,Bruno Chiarbonello,Federica Malfatti,Federica Botta,Domenico Risso,Pasquale B Lantieri,Vincenzo Savarino,Roberto Testa.Influence of Helicobacter pylori eradication therapy on 13 C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens[J].The American Journal of Gastroenterology.2000(10)
  • 8Kazunori Matsumoto MD,Makiko Suehiro PhD,Masahiro IIO MD,Tatsuo Kawabe MD,Yasushi Shiratori MD,Kenichi Okano MD,Tsuneaki Sugimoto MD.[13C]methacetin breath test for evaluation of liver damage[J].Digestive Diseases and Sciences.1987(4)
  • 9Gadi Lalazar,Tomer Adar,Yaron Ilan.Point-of-care continuous ^(13)C-methacetin breath test improves decision making in acute liver disease: Results of a pilot clinical trial[J].World Journal of Gastroenterology,2009,15(8):966-972. 被引量:6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部